Martin C Sadowski Selected Research

Martin C Sadowski Research Topics

Disease

16	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2014
14	Neoplasms (Cancer) 03/2024 - 01/2014
2	Triple Negative Breast Neoplasms 09/2021 - 06/2021
2	Genomic Instability 09/2021 - 06/2021
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2017
1	Ornithine Carbamoyltransferase Deficiency Disease 01/2022
1	Hypoadiponectinemia 12/2020
1	Obesity 12/2020
1	Hypersensitivity (Allergy) 01/2020
1	Disease Progression 01/2019
1	Leukemia 01/2016
1	Breast Neoplasms (Breast Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 01/2022 - 04/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2019
4	AndrogensIBA 01/2021 - 01/2015
3	Hormones (Hormone)IBA 01/2021 - 01/2015
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2015
2	A-Form DNA (A-DNA)IBA 09/2021 - 06/2021
2	AdipokinesIBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2015
2	CholesterolIBA 01/2019 - 01/2018
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	IsotopesIBA 01/2022
1	Aquaporins (Water Channels)IBA 01/2022
1	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 06/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	Membrane LipidsIBA 01/2021
1	LeptinIBA 01/2021
1	asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamideIBA 12/2020
1	Insulin (Novolin)FDA Link 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	AdiponectinIBA 12/2020
1	Adiponectin ReceptorsIBA 12/2020
1	diethylstilbestrol monophosphate (PDES)IBA 10/2020
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 10/2020
1	PerhexilineIBA 10/2020
1	enzalutamideIBA 01/2020
1	IronIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	psammaplysin FIBA 01/2020
1	Glutathione PeroxidaseIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	SteroidsIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	ProteomeIBA 01/2019
1	thalicthuberineIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	gibberellic acidIBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018
1	Antimitotic AgentsIBA 01/2018
1	AlkaloidsIBA 01/2017
1	Verapamil (Calan)FDA LinkGeneric 01/2016
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2015
1	eusynstyelamide BIBA 12/2015
1	PoisonsIBA 12/2015
1	CarbonIBA 07/2015
1	Tricarboxylic AcidsIBA 07/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2015
1	Glutamine (L-Glutamine)FDA Link 07/2015
1	Small Interfering RNA (siRNA)IBA 07/2015
1	NitrogenIBA 07/2015
1	E2F Transcription FactorsIBA 07/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2015
1	Antiparasitic Agents (Antiparasitics)IBA 04/2015
1	Dihydrotachysterol (AT 10)IBA 04/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2015
1	Anti-Infective Agents (Microbicides)IBA 10/2014
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 10/2014
1	Triclosan (pHisoHex)FDA Link 10/2014
1	Indicators and Reagents (Reagents)IBA 01/2014

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2015
3	Drug Therapy (Chemotherapy) 09/2021 - 01/2015
1	Castration 01/2015